Search For "clinic"
Study sheds light on potential allergic reactions of coronavirus vaccines
Updated : 5 years, 2 months ago IST
Boston (Massachusetts) [US], January 3 (ANI): A study published in the Journal of Allergy and Clinical Immunology claimed about the possible allergic reactions to new COVID-19 vaccines.
Read More
Study finds sustained cellular immune dysregulation in patients recovering
Updated : 5 years, 2 months ago IST
Birmingham [UK], January 2 (ANI): Findings from recent researches on COVID-19 and observational clinical research of COVID-19 patients can help clinicians explore more about the virus to better inform treatment and vaccine design.
Read More
COVID-19: Bharat Biotech recruits 23,000 volunteers for COVAXIN's phase 3
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 2 (ANI): Bharat Biotech has recruited 23,000 volunteers so far for the Phase III clinical trials of its COVID-19 vaccine candidate, 'COVAXIN'.
Read More
Clinical criteria for diagnosing autism inadequate for people with genetic
Updated : 5 years, 2 months ago IST
Cardiff [Wales], January 2 (ANI): The findings of a novel study suggests that more than half of individuals with one of four genetic conditions had significant autistic symptoms, despite not qualifying for a formal diagnosis.
Read More
Study: Clinical criteria for autism diagnosis inadequate for individuals w
Updated : 5 years, 2 months ago IST
Washington [US], January 2 (ANI): A new research has discovered that people with certain genetic conditions are likely to have significant symptoms of autism, despite them not qualifying by formal diagnosis.
Read More
Higher red blood cell transfusions level may cause high risk to premature
Updated : 5 years, 2 months ago IST
Virginia [US], January 1 (ANI): A randomized clinical trial lead by researchers of George Mason University has examined the blood transfusions in premature babies and their long term impacts.
Read More
Government could evaluate AstraZeneca, Covaxin: Dr Vijay Bhaskar
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], December 31 (ANI): The government could evaluate two vaccines including the indigenously researched Covaxin and AstraZeneca to address the Covid-19 pandemic, Dr Vijay Bhaskar, Chairman of the Ethics Committee, Clinical trials and research said on Thursday.
Read More
Sustained cellular immune dysregulation in individuals recovering from COV
Updated : 5 years, 2 months ago IST
Birmingham [UK], December 30 (ANI): Observational clinical research of COVID-19 patients can help clinicians better understand how the previously unknown SARS-CoV-2 virus acts, and findings from recent research can better inform treatment and vaccine design.
Read More
SA vs SL: Host bowlers shine as Proteas win by an innings and 45 runs
Updated : 5 years, 2 months ago IST
Centurion [South Africa], December 29 (ANI): Wiaan Mulder, Lutho Sipamla and Anrich Nortje all claimed two wickets apiece as the Proteas made a winning start to the summer with a clinical innings and 45-run victory over Sri Lanka after lunch on day four of the first Test against Sri Lanka at
Read More
Denta Mitra brings a Dentist to your home and offers 24x7 video consultati
Updated : 5 years, 2 months ago IST
Bengaluru (Karnataka) [India], December 28 (ANI/ PNN): Due to COVID-19, where all dental clinics were closed and driven by the idea of making dental services accessible from anywhere and anytime, awarded Public Health Dentist who is also a Professor in one of the Dental College & Hospita
Read More
AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin
Updated : 5 years, 2 months ago IST
New Delhi [India], December 24 (ANI): The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday invited volunteers for the Phase III clinical trial of the indigenously developed COVID-19 vaccine candidate 'Covaxin' for which it is one of the sites.
Read More
Aurobindo Pharma, Covaxx to develop Covid-19 vaccine for India, UNICEF
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], December 24 (ANI): Aurobindo Pharma and US-based Covaxx have entered into a license agreement to develop, commercialise and manufacture a vaccine to fight Covid-19 for India and the United Nations Children's Fund (UNICEF) agency.
Read More